Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Iradimed Corp (IRMD)

Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 577,225
  • Shares Outstanding, K 12,664
  • Annual Sales, $ 65,560 K
  • Annual Income, $ 17,190 K
  • 60-Month Beta 0.83
  • Price/Sales 8.92
  • Price/Cash Flow 32.43
  • Price/Book 7.68
Trade IRMD with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.33
  • Number of Estimates 1
  • High Estimate 0.33
  • Low Estimate 0.33
  • Prior Year 0.33
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.11 +7.34%
on 06/20/24
47.85 -5.54%
on 07/11/24
+2.89 (+6.83%)
since 06/18/24
3-Month
40.55 +11.47%
on 04/30/24
47.85 -5.54%
on 07/11/24
+4.20 (+10.24%)
since 04/19/24
52-Week
36.12 +25.14%
on 10/16/23
50.85 -11.11%
on 08/30/23
-1.21 (-2.61%)
since 07/19/23

Most Recent Stories

More News
IRadimed: Q1 Earnings Snapshot

IRadimed: Q1 Earnings Snapshot

IRMD : 45.20 (-0.83%)
IRadimed: Q4 Earnings Snapshot

IRadimed: Q4 Earnings Snapshot

IRMD : 45.20 (-0.83%)
IRadimed: Q3 Earnings Snapshot

IRadimed: Q3 Earnings Snapshot

IRMD : 45.20 (-0.83%)
IRadimed: Q2 Earnings Snapshot

IRadimed: Q2 Earnings Snapshot

IRMD : 45.20 (-0.83%)
IRadimed: Q1 Earnings Snapshot

IRadimed: Q1 Earnings Snapshot

IRMD : 45.20 (-0.83%)
IRadimed: Q4 Earnings Snapshot

IRadimed: Q4 Earnings Snapshot

IRMD : 45.20 (-0.83%)
3 Healthcare Stocks With High Profit Margins

If you want to invest in profitable healthcare companies in this bear market, these all look like good bets.

DOCS : 28.22 (+2.28%)
IRMD : 45.20 (-0.83%)
GILD : 72.56 (-1.29%)
IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results

Reports second quarter 2022 revenue of $12.7 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.26Announces third quarter 2022 financial...

IRMD : 45.20 (-0.83%)
UPDATE - IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th

WINTER SPRINGS, Fla., July 28, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second...

IRMD : 45.20 (-0.83%)
IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th

WINTER SPRINGS, Fla., July 22, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second...

IRMD : 45.20 (-0.83%)

Business Summary

iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump...

See More

Key Turning Points

3rd Resistance Point 46.74
2nd Resistance Point 46.35
1st Resistance Point 45.78
Last Price 45.20
1st Support Level 44.81
2nd Support Level 44.42
3rd Support Level 43.85

See More

52-Week High 50.85
Fibonacci 61.8% 45.22
Last Price 45.20
Fibonacci 50% 43.48
Fibonacci 38.2% 41.75
52-Week Low 36.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar